| 1848 |
 |
Shozo Akazawa, the 5th head of the family, obtains a certificate granting him permission from the government to deal in medicines, and starts business |
|
 |
|
Governmental certificate giving
permission to deal in medicines |
|
|
|
|
 |
| 1883 |
|
Chutaro Akazawa obtains a license to operate a pharmacy |
|
|
‘Honzo-zufu’, a botanical encyclopedia
from the time of Akazawa-Yakkan
(trade name) |
|
 |
|
|
|
| 1892 |
|
Permission to sell rodent repellant obtained, marking the beginning of the business in the field |
|
|
| 1918 |
|
Teikoku Seiyaku Co., Ltd. established with capital of 1 million yen |
|
 |
|
| Plant at the time of establishment |
|
|
|
|
|
| 1926 |
|
Chemical Cat, yellow phosphorous-based rodent poison, launched |
|
|
| Drugs, circa 1920 |
|
|
|
 |
|
Caps and bags
of company peddlers,
circa 1925 |
|
|
|
 |
|
|
|
| 1938 |
|
Horxis, a prototype of the current medicated plaster, launched |
|
|
| 1943 |
|
A group of 212 companies in Kagawa Prefecture join together to establish Kagawa Prefecture Pharmaceutical Co., Ltd. and Chutaro Akazawa is appointed as the first president |
|
|
| 1953 |
|
Osaka Plant established in Yodogawa-ku (former Higashi-yodogawa-ku), Osaka |
|
|
| 1957 |
|
Osaka Plant spun off as Fuso Chemical Industry Co., Ltd. and Shozo Akazawa, the 9th generation of the family, appointed president |
|
|
| 1974 |
|
Teikoku Seiyaku’s medicated plasters approved for prescription use, becoming the company’s main product line |
|
|
| 1975 |
|
First stage of new production plant for plasters (former Plant No.1) completed
Final stage of construction completed in 1978 |
|
|
 |
|
| Products manufactured, 1975 |
|
|
|
|
|
| 1984 |
|
Nine-story pharmaceutical development laboratory (present Administration Bldg.) completed at the site of headquarters complex |
|
|
|
|
| 1985 |
|
Teikoku Kampo Seiyaku Co., Ltd. established
New Shirotori Plant completed in Shirotori-cho (now Minato, Higashikagawa), Kagawa Prefecture |
|
|
| 1986 |
|
Teikoku Seiyaku acquires stock in Ohta Pharmaceutical Co., Ltd. and starts participating in management |
|
|
| 1988 |
|
Catlep, Japan’s first transdermal indomethacin plaster for prescription use, approved and production begins
New plant (present Plant No.2), 5 stories and 6,451 square meters, completed at the site of headquarters complex |
|
|
|
| Catlep |
|
|
 |
|
New plant at time of
completion (Now Plant No.2) |
|
|
|
 |
|
|
|
| 1989 |
|
Distribution Center completed in Shirotori-cho (now Minato, Higashikagawa), Kagawa Prefecture |
|
 |
|
| Shirotori Distribution Center |
|
|
|
|
|
| 1991 |
|
Company contributed to the Department of Pharmaco-Bio-Informatics, established at Kagawa Medical University (Now Faculty of Medicine, Kagawa University) |
|
|
| 1992 |
|
Sales division spun off as an independent company, Teikoku Medix Co., Ltd. |
|
|
| 1993 |
|
Construction of Plant No.4 dedicated to manufacture of tapes and ointments completed
Ikeda Plant dedicated to manufacture of rodent poison begins operations in Ikeda-cho, Tokushima Prefecture
Seltouch, a transdermal felbinac plaster for prescription use, approved and production begins |
|
|
| 1994 |
|
Production begins at Tokushima Plant (Teikoku Kampo Seiyaku Co., Ltd.) |
|
|
|
|
| 1995 |
|
Non-prescription drug division (OTC) spun off as an independent company, Teikoku Pharmacare Co., Ltd.
Teikoku Seiyaku joins the Japan Pharmaceutical Manufacturers Association |
|
|
| 1997 |
|
Site of the former Sanbonmatsu Plant of Toyobo Co., Ltd., adjacent to Teikoku Seiyaku headquarters, acquired
U.S. subsidiary, Teikoku Pharma USA, Inc., established
Land adjacent to Tokushima Plant acquired and Donari Plant dedicated to manufacture of cosmetics and related products begins operations |
|
|
| 1998 |
|
150th anniversary of the founding of the business and 80th anniversary of the establishment of the company celebrated
"Sogyo 150-Nen Shi” (History of the First 150 Years) published |
|
 |
|
| Symbol of the 150th Anniversary |
|
|
|
|
|
| 1999 |
|
Lidoderm, the analgesic plaster for the treatment of post-herpetic neuralgia, approved and launched in the U.S. |
|
|
| 2000 |
|
Dovonex ointment approved and launched
Construction of Plant No.8 completed at the site of former Toyobo Co., Ltd. and production begins |
|
|
| 2001 |
|
UK subsidiary, Teikoku Pharma UK Ltd., established
MS-Twicelon Capsule, a sustained-release morphine sulfate product, approved and production begins
Production begins at new Plant No.7 |
|
|
| 2003 |
|
Fuso Teiyaku (Qingdao) Co., Ltd., established
New pharmacology building completed |
|
|
| 2004 |
|
Teikoku Pharma USA, Inc. moves into a new building with a new manufacturing plant |
|
|
|
|
| 2006 |
|
Acquires the right to exclusively develop and market the fast-acting pulmonary delivery fentanyl formulation from LAB (Finland) and the pulmonary delivery kit formulation from Altea (USA) in Japan
Formulation research building completed at the site of Sanbonmatsu Plant
Teikoku Pharmacare Co., Ltd. launches OMNEED® Ketoprofen Patch, the first OTC ketoprofen patch in Japan
Tokyo Office moves into Teikoku’s own building in Nihonbashi-honcho |
|
|
| 2007 |
|
Teikoku Seiyaku Memorial Gallery, Akazawa Memorial Gallery and Guest House "FUTAGOJIMA" completed |
|
|
 |
|
Teikoku Seiyaku
Memorial Gallery |
|
|
|
 |
|
Guest House
"FUTAGOJIMA" |
|
|
|
|
|
| 2008 |
|
160th anniversary of the founding of the business and 90th anniversary of the establishment of the company celebrated
Teikoku Medix Co., Ltd. sold |
|
